Compare
Mitesco, Inc. vs Transuite.org Inc. vs Bioregenx, Inc. vs Real Messenger Corp
| Latest fiscal year | Mitesco, Inc. MITIRevenue covers only part of its income (partial revenue) | Transuite.org Inc. TRSO | Bioregenx, Inc. BRGX | Real Messenger Corp RMSG |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-03-31 |
| Revenue | n/a | $117.8K | $1.85M | $29.5K |
| Revenue growth (YoY) | n/a | n/a | -20.8% | n/a |
| Gross margin | n/a | 99.8% | 81.1% | 51.5% |
| Operating margin | n/a | n/m | -67.1% | n/m |
| Net margin | n/a | n/m | -83.2% | n/m |
| Net income | $498.7K | -$37.16M | -$1.54M | -$4.09M |
| EPS (Diluted) | -$0.14 | -$1.52 | $0.00 | -$0.44 |
| Operating cash flow | -$701.6K | -$69.3K | $39.0K | -$3.57M |
| Free cash flow | n/a | n/a | $29.9K | -$3.58M |
| Cash & equivalents | $100.9K | $3.7K | n/a | $322.0K |
| Total assets | $132.1K | $337.5K | $411.0K | $995.4K |
| Total liabilities | $23.60M | $809.9K | $4.95M | $508.5K |
| Shareholders' equity | -$23.47M | -$485.1K | -$4.54M | $486.8K |
| Return on year-end equity | n/a | n/a | n/a | -840.6% |
| Shares outstanding | 15.09M | 2.14M | 969.02M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Mitesco, Inc. | Transuite.org Inc. | Bioregenx, Inc. | Real Messenger Corp |
|---|---|---|---|---|
| Latest | n/a | $117.8K Ended 2025-12-31 | $1.85M Ended 2025-12-31 | $29.5K Ended 2026-03-31 |
| 1 year earlier | n/a | $0 Ended 2024-12-31 | $2.34M Ended 2024-12-31 | n/a |
| 2 years earlier | n/a | n/a | $3.41M Ended 2023-12-31 | n/a |
| 3 years earlier | n/a | n/a | $42.2K Ended 2022-12-31 | n/a |
| 4 years earlier | n/a | n/a | $198.6K Ended 2021-12-31 | n/a |